Guidance Issued for Safe Use of GLP-1 RAs in the Perioperative Period
TUESDAY, Nov. 5, 2024 -- In a multisociety clinical practice guidance document, published online Oct. 29 in Surgery for Obesity and Related Diseases, recommendations are presented for the safe use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in the perioperative period.
Noting that GLP-1 RAs have revolutionized the care of patients with metabolic disease, Tammy L. Kindel, M.D., Ph.D., from the Medical College of Wisconsin in Milwaukee, and colleagues developed recommendations for the safe use of GLP-1 RAs in the perioperative period.
The authors recommend that GLP-1 RA use in the perioperative period should be based on shared decision-making of the patient with procedural, anesthesia, and prescribing care teams, focusing on balancing the metabolic need for GLP-1 RAs with patient risk. Variables that elevate the risk for delayed gastric emptying and aspiration should be considered, with their assessment occurring with enough time before surgery to allow for adjustments in perioperative care, if needed. Safe GLP-1 RA use should include efforts to minimize the aspiration risk of delayed gastric emptying, which can be achieved by preoperative diet modification and/or altering anesthesia. In cases with concern for delayed gastric emptying, preoperative diet modification (a preoperative liquid diet for at least 24 hours) can be utilized.
"This multisociety clinical practice document should be considered guidance and not an evidence-based guideline, focusing on shared decision-making and balancing safety processes with therapeutic metabolic need for the safe continuation of surgical and procedural care in patients taking GLP-1 RAs," the authors write.
Several authors disclosed ties to the pharmaceutical and medical device industries.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Read this next
Remote Perioperative Telemonitoring Beneficial After Cancer Surgery
THURSDAY, Sept. 25, 2025 -- Remote perioperative telemonitoring (RPM) improves postoperative functional recovery and symptoms among patients undergoing surgery for cancer...
Shunt Surgery Beneficial in Idiopathic Normal-Pressure Hydrocephalus
TUESDAY, Sept. 23, 2025 -- Shunt surgery significantly improves gait velocity at three months among patients with idiopathic normal-pressure hydrocephalus with a response to...
Photorefractive Keratectomy Safe, Effective for Teenagers
TUESDAY, Sept. 23, 2025 -- Photorefractive keratectomy (PRK) is safe and effective for teenagers, with visual outcomes comparable to or slightly better than in adults, according...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.